Healthcare
Live Price
Offline$0.912
-1.30% today
1Y Change
-34.46%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
TScan Therapeutics, Inc. (TCRX) is a Healthcare stock with a market cap of $70.00M and listed on NASDAQ. The stock last traded around $0.91 and down 34.5% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +266.7%, EPS growth of +12.3%, a dividend yield of 0.0%. What stands out right now is revenue +266.7%, EPS +12.3%, free cash flow -21.9% with operating margin -1315.4% and ROIC -62.5%. Valuation sits in the middle of the pack at price/sales 6.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines TCRX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TCRX
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TCRX Max Drawdown
-64.44%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TCRX and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.